MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/ijms252312596

Медицинская библиотека · International journal of molecular sciences · 2024

Advances in Tumor-Infiltrating Lymphocyte (TIL) as a Prognostic Factor and for Treating Invasive Cutaneous Melanoma.

de Oliveira Gabriel Alves Freiria, de Oliveira Daniel Arcuschin, Nisimoto Melissa Yoshimi Sakamoto Maeda, Rubinho Rafael, Gomes Heitor Carvalho, Marti Luciana Cavalheiro, de Oliveira Filho Renato Santos

СтатьяОбзорПеревод пока не подготовлен

Аннотация

Invasive cutaneous melanoma is responsible for about 5% of skin tumors yet is liable for nearly 70% of skin cancer-related deaths. Despite notable advancements over the past decade, including immunotherapies and targeted treatments, more than half of invasive melanoma patients ultimately succumb to the disease due to therapeutic resistance. To overcome this obstacle, strategies such as combining immunotherapies with targeted drugs or adding epigenetic therapies have been investigated. Tumor-infiltrating lymphocytes (TILs) therapy has emerged as a promising option for patients whose disease continues to progress despite standard treatments. This article aims to introduce TIL therapy and review recent outcomes in melanoma prognosis in its application for melanoma management.

Для цитирования: de Oliveira Gabriel Alves Freiria, de Oliveira Daniel Arcuschin, Nisimoto Melissa Yoshimi Sakamoto Maeda, Rubinho Rafael, Gomes Heitor Carvalho, Marti Luciana Cavalheiro, de Oliveira Filho Renato Santos. Advances in Tumor-Infiltrating Lymphocyte (TIL) as a Prognostic Factor and for Treating Invasive Cutaneous Melanoma.. International journal of molecular sciences. 2024. DOI: 10.3390/ijms252312596.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.